a result, NUSA was required to amend its financial statements to ensure disclosure of accurate information. However, it has been found that the annual financial statements for the year 2023 and the
Bangkok, March 5, 2012 ? The SEC board is proposing to amend the Provident Fund Act of 1987 in the following areas:(1) Employee will be able to pay savings into the fund at the rate higher than
Bangkok, 6 January 2017 ? The SEC has ordered K.C. Property Public Company Limited (KC) to amend its annual financial statements for the year 2015 and the interim financial statements for the third
Bangkok, July 31, 2014 ? The SEC ordered Richy Place 2002 Plc. (RICHY) to amend information in the registration statement concerning comparison of P/E ratios of the company and the industry to be
is therefore proposing to amend the governing rules and regulations, as summarized below:(1) In addition to the existing requirements for reporting initial public offering (IPO) results (Form 81-1-IPO
Pursuant to the existing regulations that have been effective since 2004, listed companies are required to pay an annual fee for submission of the annual registration statement to the SEC. In this regard, the annual fee is calculated based on the shareholders’ equity presented in the financial statements for the latest accounting year that have been submitted to the SEC. In case of a listed company not submitting the latest annual financial statements within the specified period, the SEC will ca...
Date of EGM 1/2020 (Revise) Dear Directors and Managers Stock of Exchange of Thailand Attachment 1. Extraordinary General Meeting of Shareholders No. 1/2020 2. Information Regarding the Asset Acquisition
Microsoft Word - IP_OCS_011 มติ BOD4_T 2020_revise บร ิษัท อ ินเตอร ์ฟารม์า จาํกัด (มหาชน) เลขท ี / อาคารไอทเีอฟ ชัน ถนนสีลม แขวงสุร ิยวงศ ์เขตบางร ัก กรุงเทพมหานคร โทรศัพท ์ - - แฟ็กซ ์ - 34-0135 www.interpharma.co.th Inter Pharma Public Company Limited 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawongse, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th IP_OCS/011/2563 8 มิถนุายน 2563 เรอืง แจง้มติทีประชมุคณะกรรมการบรษัิท, การเปลียนแปลงวตัถปุระสงคก์ารใชเ...
The SEC proposes to revise the IA refresher course regulations to enhance their knowledge review criteria to be more appropriate and serve the needs of their roles and responsibilities. A previous